Key Takeaways
- Beyond Meat’s Q4 2025 earnings release is scheduled for after market close Tuesday, March 31, postponed from March 25 following disclosure of “material weaknesses” in financial reporting controls.
- Analysts forecast approximately $63 million in quarterly revenue—representing an 18% decline year-over-year—with an expected loss of $0.10 per share.
- The options market is anticipating a dramatic 30% price movement following the announcement—significantly exceeding the stock’s historical 7–10% post-earnings volatility.
- The company faces a Nasdaq delisting warning after closing below $1 per share for 30 consecutive trading days, with a compliance deadline of August 31, 2026, potentially forcing a reverse stock split.
- Despite challenges, major institutional investors increased positions dramatically in Q4—Geode Capital by 445%, Charles Schwab by 497%, and Virtu by 670%—bringing institutional ownership to 52.48%.
The plant-based protein pioneer that once captivated growth investors has transformed into a sub-dollar stock preparing for potentially its most pivotal earnings announcement to date.
The alternative meat producer will unveil Q4 2025 financial results following Tuesday’s closing bell on March 31. Initially slated for March 25, the announcement was postponed after management identified “material weaknesses” in the company’s internal financial reporting controls. The delay itself triggered investor concern.
Consensus estimates call for quarterly revenue near $63 million, though Beyond Meat has already preannounced lower figures—preliminary company guidance indicates Q4 revenue closer to $61 million. This shortfall versus Street expectations underscores persistent demand headwinds. Full-year revenue is projected to decline approximately 10% to $275 million.
The per-share loss is anticipated at roughly $0.10, representing a significant improvement from the $0.65 loss recorded in the year-ago quarter. This narrowing loss represents one of few positive data points entering Tuesday’s release.
On March 16, the company announced it was delaying its annual 10-K submission to conduct additional inventory reconciliation. Mizuho analyst John Baumgartner, maintaining an Underperform rating with a $1 price objective, flagged this development as concerning. He highlighted softening demand across core channels and noted the company’s protein beverage expansion faces formidable competitive pressures.
The analyst community remains overwhelmingly negative. Six firms rate BYND as Sell, two maintain Hold positions, and the average price target sits at $1.70—substantially above current trading levels. Weiss Ratings reiterated a “sell (e+)” recommendation in January.
Nasdaq Delisting Risk and Compliance Deadline
Beyond the quarterly results, the company confronts an additional challenge. Beyond Meat received a Nasdaq minimum bid price deficiency notice after trading below $1 per share for 30 consecutive business days. Management has until August 31, 2026, to regain compliance by sustaining a closing price above $1. Failure to meet this requirement would likely necessitate a reverse stock split.
Shares have plummeted approximately 77% during the trailing 12-month period. The stock’s 50-day moving average sits at $0.78, while the 200-day moving average stands at $1.28—both meaningfully above current price levels.
Derivatives Market Forecasts Exceptional Volatility
Options pricing suggests a potential 30% directional move following the earnings release. This implied volatility dramatically exceeds Beyond Meat’s typical 7–10% post-earnings price swing by a factor of three to four.
To contextualize, a 30% movement from $0.65 establishes a probable trading range between approximately $0.46 and $0.85. The downside scenario would approach the stock’s all-time low of $0.50.
Interestingly, select institutional investors substantially increased exposure during Q4. Geode Capital Management expanded holdings by 445%, Charles Schwab increased its stake by 497%, and Virtu Financial boosted its position by 670%. Institutional ownership now comprises approximately 52.48% of outstanding shares.
The analyst community remains predominantly cautious, citing ongoing revenue pressure, unresolved accounting control issues, and the ticking Nasdaq compliance deadline that began in early 2026.
